Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy
Abstract
1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Burchell, H.B.; Wood, E.H. Reflex orthostatic dyspnea associated with pulmonary hypotension. Am. J. Physiol. 1949, 159, 563–564. [Google Scholar]
- Seward, J.B.; Hayes, D.L.; Smith, H.C. Platypnea-orthodeoxia: Clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin. Proc. 1984, 59, 221–231. [Google Scholar] [CrossRef]
- Henkin, S.; Negrotto, S.; Pollak, P.; Cullen, M. Platypnea-Orthodeoxia Syndrome: Diagnostic Challenge and the Importance of Heightened Clinical Suspicion. Tex. Heart Inst. J. 2015, 42, 498–501. [Google Scholar] [CrossRef] [PubMed]
- Rodrigues, P.; Palma, P. Platypnea-orthodeoxia syndrome in review: Defining a new disease? Cardiology 2012, 123, 15–23. [Google Scholar] [CrossRef] [PubMed]
- Shovlin, C.L.; Chamali, B.; Santhirapala, V. Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: Associations with iron deficiency and platelets. PLoS ONE 2014, 9, e88812. [Google Scholar] [CrossRef]
- Neuvillers, L.; Masri, A.; Veugeois, A.; Diakov, C. Platypnea–orthodeoxia syndrome: Comprehensive analysis by multimodal imaging. Eur. Heart J. 2021, 42, 3995. [Google Scholar] [CrossRef]
- Crosbie, P. A rare complication of pneumonectomy: Diagnosis made by a literature search. Respir. Med. 2005, 99, 1198–1200. [Google Scholar] [CrossRef]
- Califano, R.; Hsu Julie, H.S.; Summers, Y. Platypnea-orthodeoxia syndrome following left pneumonectomy for early stage non-small cell lung cancer. Cancer Treat. Commun. 2014, 2, 1–3. [Google Scholar] [CrossRef]
- Bellato, V.; Brusa, S.; Balazona, J. Platypnea-orthodeoxia syndrome in interatrial right to left shunt postpneumonectomy. Min. Anestes. 2008, 74, 271–275. [Google Scholar]
- Porter, B.S.; Hettleman, B. Treatment of Platypnea-Orthodeoxia Syndrome in a Patient with Normal Cardiac Hemodynamics: A Review of Mechanisms with Implications for Management. Methodist DeBakey Cardiovasc. J. 2018, 14, 141–146. [Google Scholar] [CrossRef]
- Krassas, A.; Tzifa, A.; Boulia, S. Posture Dependent Hypoxia Following Lobectomy: The Achilles Tendon of the Lung Surgeon? J. Investig. Surg. 2022, 35, 180–185. [Google Scholar] [CrossRef]
- Smeenk, F.W.J.; Postmus, P.E. Interatrial right-to-left shunting developing after pulmonary resection in the absence of elevated right-sided heart pressures. Review of the literature. Chest 1993, 103, 528–531. [Google Scholar] [CrossRef]
- Marini, M.; Miniati, N.; Ambrosino, B. Dyspnoea and hypoxaemia after lung surgery: The role of interatrial right-to-left shunt. Eur. Respir. J. 2006, 28, 174–181. [Google Scholar] [CrossRef]
- Agrawal, A.; Palkar, A.; Talwar, A. The multiple dimensions of platypnea-orthodeoxia syndrome: A review. Respir. Med. 2017, 129, 31–38. [Google Scholar] [CrossRef]
- Cheng, T.O. Mechanisms of platypnea-orthodeoxia: What causes water to flow uphill? Circulation 2002, 105, e47. [Google Scholar] [CrossRef]
- Devendra, G.P.; Rane, A.A.; Krasuski, R.A. Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure. JACC Cardiovasc. Interv. 2012, 5, 416–419. [Google Scholar] [CrossRef]
- Baumgartner, F.; Omari, B.; Lee, J. Survival after trauma pneumonectomy: The pathophysiologic balance of shock resuscitation with right heart failure. Am. Surg. 1996, 62, 967–972. [Google Scholar]
- Robin, E.D.; McCauley, R.F. An analysis of platypnea-orthodeoxia syndrome including a “new” therapeutic approach. Chest 1997, 112, 1449–1451. [Google Scholar] [CrossRef]
- Othman, F.; Bailey, B.; Collins, N. Platypnea-Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease. J. Am. Heart Assoc. 2022, 11, e024609. [Google Scholar] [CrossRef]
- D’Mello, A.C.; Haji, K.; Moir, S. Platypnea-orthodeoxia syndrome after right lower lobectomy for lung cancer. Oxf. Med. Case Rep. 2019, 2019, omy049. [Google Scholar] [CrossRef]
- Sakagianni, K.; Evrenoglou, D.; Mytas, D. Platypnea-orthodeoxia syndrome related to right hemidiaphragmatic elevation and a ‘stretched’patent foramen ovale. Case Rep. 2012, 2012, bcr-2012. [Google Scholar]
- Guérin, P.; Lambert, V.; Godart, F. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: Results of a multicentric French registry. Cardiovasc. Interv. Radiol. 2005, 28, 164–168. [Google Scholar] [CrossRef] [PubMed]
- Mojadidi, M.K.; Gevorgyan, R.; Noureddin, N. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome. Catheter. Cardiovasc. Interv. 2015, 86, 701–707. [Google Scholar] [CrossRef] [PubMed]
Recovery Day | Signs and Symptoms | Blood Tests | Instrumental Investigation | Treatment | |
---|---|---|---|---|---|
Day -1 | Good clinical conditions | CBC | Hb: 12.5 g/dL WBC: 9.16 × 103 μL | ECG: sinus rhythm Echocardiography: ASA without a shunt. EF 60% SARS-CoV test: negative | |
Day 0 SURGERY | SpO2: 90–100% BP: 110/90 mmHg HR: 70 bpm | CBC ABG | Hb 9.5 g/dL WBC 13.61 × 103μL pH 7.41 pO2 68 mmHg pCO2 42 SO2 96% | Chest X-ray: incomplete right lung expansion | Single-unit blood transfusion Antibiotic therapy Oxygen therapy (nasal cannula, 4 L/min) |
Day 1 | In the morning episode of sudden desaturation (SpO2 80%) Soporose state Anisocoria SpO2: 100% BP: 90/55 mmHg HR: 70 bpm | CBC ABG | Hb: 9.8 g/dL WBC: 12.03 × 103 μL: pH 7.4 pO2 50 mmHg pCO2 41 mmHg SO2 88% | TTE: ASA without a shunt Brain CT scan: two small thalamic areas attributable to suspicious ischemic lesions EEG: stage N1–N2 sleep | Tracheobronchial toilet Corticosteroids Oxygen therapy (Venturi mask 15 L) |
Day 2 | Awake and active SpO2 100% BP: 100/60 mmHg HR: 60 bpm | CBC ABG | Hb: 8.7 g/dL WBC: 9.06 × 103 μL pH 7.4 pO2 78 mmHg pCO2 43 mmHg SO2 98% | Chest X-ray: incomplete right lung expansion Brain CT scan: stable | Single-unit blood transfusion Neuro-rehabilitation exercises |
Day 3 | Acute neurologic deficit with left-sided paralysis SpO2 100% BP: 120/70 mmHg HR: 60 bpm | CBC | Hb: 9.7 g/dL WBC: 7.71 × 103 μL | Chest X-ray: stable CT neck\brain angiography: stable | Supine position Acetylsalicylic acid 100 mg Atorvastatin 20 mg |
Day 4 | Awake and stable SpO2 100% BP: 130/90 mmHg HR: 80 bpm An episode of autonomous mobilization, with SpO2 84% | CBC ABG | Hb: 10.1 g/dL WBC: 6.51 × 103 μL pH 7.55 pO2 41 mmHg pCO2 37 mmHg sO2 85% | Chest X-ray stable | Supine position Oxygen therapy (Venturi mask 15 L) |
Day 5 | Awake and stable SpO2 100% BP: 120/70 mmHg HR: 60 bpm | CBC | Hb: 11 g/dL WBC: 5.61 × 103 μL CRP 2.76 mg/dL | Supine position Removal of basal chest drainage | |
Day 6 | Awake and stable SpO2 90–100% BP: 120/70 mmHg HR: 70 bpm | Brain CT scan: stable | Partial mobilization | ||
Day 7 | Postural dyspnea SpO2 80% BP: 120/80 mmHg HR: 110 bpm | ABG 9 am ABG 4 pm | Hb: 10.9 g/dL WBC: 7.85 × 103 μL CRP: 1.63 mg/dL pH 7.53 pO2 37 mmHg pCO2 38 mmHg Lac 2.0 mmol/L SO2: 78% Ph 7.61 pO2 37 mmHg pCO2 27 mmHg SO2 80% | Chest X-ray: stable CT chest angiography: no signs of pulmonary embolism ECG: sinus rhythm TTE: EF 60%, ASA COVID-19 test negative | Clopidogrel 75 mg Oxygen therapy (Venturi mask 15 L) |
Days 8–11 Intensive care unit | ABG | pH 7.46 pO2 126 mmHg pCO2 41 mmHg SO2 97.5% | Intensive monitoring | Noninvasive ventilation Pression support 14 cm H2O Peep3 cm H2O FiO2 35% Sildenafil 25 mg Blood transfusion | |
Days 12–15 | Awake and stable SpO2: 91–100% BP: 110/60 mmHg HR: 60–70 bpm | CBC ABG | Hb: 11.3 g/dL WBC: 7.64 × 103 μL pH 7.45 pO2 63 mmHg pCO2 40 mmHg SO2 93.3% | Chest X-ray: complete right lung expansion COVID-19 test: negative | Oxygen therapy (nasal cannula, 3–5 L/min) Removal of apical chest drainage |
Day 16 | Awake and active SpO2: 85–100% BP: 110/75 mmHg HR: 70 bpm | ABG | pH 7.46 pO2 55 mmHg pCO2 33 mmHg SO2 90.6% Lac 0.7 mmol/L | TEE: interatrial septal aneurysm 2 L according to Olivares-Reyes classification. Interatrial communication, attributable to patent foramen ovale (PFO), with the flow of microbubbles in basal portion, after intravenous injection of microbubble contrast agent Enhanced transcranial Doppler ultrasound: microemboli in the basal cerebral arteries, diagnostic for permanent right-to-left shunt. | Oxygen therapy (Venturi mask 15 L) |
Day 17 | Awake and active SpO2 100% BP: 130/70 mmHg HR: 60 bpm | Oxygen therapy (Venturi mask 15 L) | |||
Day 18 | Episode of desaturation SpO2 80% BP 100/70 mmHg HR: 95 bpm | CBC | Hb: 12.5 g/dL WBC: 8.2 × 103 μL | ECG: sinus rhythm | Bisoprolol 1.25 mg Polygeline 500 mL Oxygen therapy (Venturi mask 15 L) |
Days 19–23 | Awake and stable | CBC | Hb: 11.5 g/dL WBC: 6.93 × 103 μL CRP: 1.43 mg/dL | Chest X-rays: stable | Oxygen therapy (nasal cannula, 3 L/min) |
Day 24 | Percutaneous closure of PFO | CBC | Hb: 9.9 g/dL WBC: 6.48 × 103 μL | via transesophageal echocardiogram-guided Amplatzer Multifenestrated Septal Occluder | |
Day 25 | Awake and stable | CBC | Hb: 9.2 g/dL WBC: 6.94 × 103 μL | TTE: minimal residual shunt | |
Day 26–27 | Awake and stable in the upright position SpO2 97% | CBC | Hb: 10 g/dL WBC: 6.9 × 103 μL | Chest X-ray: stable | Rehabilitation exercises |
Day 28 | SpO2 97% BP 112/70 mmHg HR 80 bpm | Hospital discharge |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zirafa, C.C.; Lenzini, A.; Spontoni, P.; Cariello, C.; Doroni, L.; Pieroni, A.; Petronio, A.S.; Melfi, F. Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy. Surgeries 2023, 4, 164-174. https://doi.org/10.3390/surgeries4020018
Zirafa CC, Lenzini A, Spontoni P, Cariello C, Doroni L, Pieroni A, Petronio AS, Melfi F. Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy. Surgeries. 2023; 4(2):164-174. https://doi.org/10.3390/surgeries4020018
Chicago/Turabian StyleZirafa, Carmelina C., Alessandra Lenzini, Paolo Spontoni, Claudia Cariello, Luca Doroni, Adrea Pieroni, Anna S. Petronio, and Franca Melfi. 2023. "Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy" Surgeries 4, no. 2: 164-174. https://doi.org/10.3390/surgeries4020018
APA StyleZirafa, C. C., Lenzini, A., Spontoni, P., Cariello, C., Doroni, L., Pieroni, A., Petronio, A. S., & Melfi, F. (2023). Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy. Surgeries, 4(2), 164-174. https://doi.org/10.3390/surgeries4020018